+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Breast Lesion Localization Methods Market - Global Forecast to 2030- Product Image
Breast Lesion Localization Methods Market - Global Forecast to 2030- Product Image
Sale

Breast Lesion Localization Methods Market - Global Forecast to 2030

  • PDF Icon

    Report

  • 181 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6011431
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Breast Lesion Localization Methods Market grew from USD 1.39 billion in 2024 to USD 1.61 billion in 2025. It is expected to continue growing at a CAGR of 15.85%, reaching USD 3.36 billion by 2030.

Breast lesion localization has evolved into a critical pillar of modern oncological care, serving as the gateway between early detection and precise surgical intervention. Accurate positioning of suspected lesions reduces operative time, minimizes healthy tissue removal and enhances post-operative outcomes. The convergence of imaging innovations, marker-based approaches and minimally invasive techniques has transformed how surgeons plan and execute procedures. Stakeholders across the healthcare continuum-from radiologists and surgeons to medical device manufacturers and payers-face mounting pressure to adopt solutions that optimize clinical efficacy while controlling costs.

Today’s landscape encompasses an array of methods: advanced techniques such as cryoablation and robotic-guided placement; emerging modalities including AI-powered and augmented reality-guided systems; established imaging modalities like MRI, mammography and ultrasound; and marker-based methods ranging from traditional wire guidance to non-radioactive and radioactive seed localization. This report delves into each domain, assesses regulatory and trade influences, and provides actionable intelligence for decision-makers aiming to navigate and lead in this rapidly shifting field.

Transformative Shifts Reshaping the Localization Landscape

Over the past decade, breast lesion localization has undergone transformative shifts driven by technological breakthroughs and shifting clinical priorities. Cryoablation and robotic-assisted localization have elevated precision and reduced patient trauma, while augmented reality overlays and artificial intelligence have accelerated lesion detection and real-time guidance accuracy. Integration of AI-powered solutions into standard imaging workflows has improved diagnostic confidence and reduced false-negative rates, prompting leading centers to redesign care pathways around cross-disciplinary collaboration between radiology and surgery teams.

Meanwhile, marker-based innovations such as non-radioactive seed localization have surpassed wire-guided techniques in patient comfort and scheduling flexibility. The democratization of high-resolution optical imaging alongside the consolidation of imaging software platforms has spurred adoption among diagnostic centers and ambulatory surgery facilities. Regulatory bodies are increasingly focused on safety standards for AI algorithms and device interoperability, further shaping vendor roadmaps. Collectively, these advances are redefining best practices and setting new benchmarks for treatment timelines, patient satisfaction and overall clinical outcomes.

Cumulative Impact of U.S. Tariffs on Localization Technologies

In 2025, the introduction of new United States tariffs on imported medical devices and components has had a cumulative ripple effect across the breast lesion localization ecosystem. Devices such as MRI-compatible markers, specialized ultrasound transducers and radioactive seed delivery instruments have seen cost structures recalibrated, prompting vendors to reevaluate supply chains and consider near-shoring production. Diagnostic centers and hospitals have encountered heightened procurement expenses, leading to extended amortization schedules or in some cases delayed equipment upgrades.

Manufacturers have responded by diversifying material sourcing, renegotiating supplier contracts and offering bundled service agreements to mitigate sticker shock. Software providers, while less directly exposed to import levies, have faced indirect pressures as capital budgets prioritize essential hardware. The tariffs have also stimulated domestic manufacturing partnerships and galvanized investment in localized assembly facilities, contributing to regional job creation and supply chain resilience. Overall, the policy shift underscores the importance of flexible procurement strategies and proactive stakeholder engagement in navigating evolving trade landscapes.

Key Segmentation Insights Driving Adoption

A multi-dimensional segmentation analysis reveals distinct patterns behind technology adoption and end-user preferences. Among technology types, advanced techniques like cryoablation and robotic-assisted localization command premium positioning in high-volume surgical centers, while AI-powered solutions and augmented reality guided approaches are rapidly gaining traction in research institutes and leading hospitals. Traditional imaging-based methods-including MRI, mammography, optical imaging and ultrasound-remain foundational, particularly within diagnostic centers that prioritize non-invasive, high-throughput workflows. Marker-based solutions continue to evolve: non-radioactive seed localization offers scheduling flexibility, radioactive seed localization ensures high positional accuracy, and wire-guided localization retains relevance in resource-constrained settings.

End-user segmentation highlights hospitals and clinics-both private clinics and public hospitals-as primary adopters, leveraging multidisciplinary teams to integrate new localization modalities. Ambulatory surgery centers and diagnostic centers demonstrate selective uptake of minimally invasive procedures, while research institutes incubate next-generation technologies.

Product type distinctions underscore the expanding footprint of software solutions alongside devices. Handheld devices and stationary systems support intraoperative guidance, whereas imaging software platforms drive algorithmic lesion detection and surgical planning. Age group segmentation indicates that adult populations-spanning young, middle-aged and senior adults-represent the majority of procedures, with pediatric cases accounting for a smaller but growing niche. Provider type analysis shows that specialists, notably oncologists and radiologists, spearhead adoption, supported by primary care providers who contribute to referral pipelines. Finally, lesion type insights reveal that malignant cases-especially ductal and lobular carcinoma-dominate procedural volumes, while benign lesions continue to benefit from less invasive monitoring. Degree of invasiveness segmentation points to a clear shift toward minimally invasive procedures backed by patient demand for quicker recovery and reduced scarring.

Key Regional Insights Influencing Market Growth

Regional dynamics shape market trajectories as well. In the Americas, well-established reimbursement frameworks and advanced clinical infrastructure have fostered rapid uptake of both imaging-based and marker-based localization methods, supported by robust R&D investments. Europe, the Middle East and Africa demonstrate heterogeneous growth: Western Europe’s stringent regulatory environment coexists with strong public health systems that champion minimally invasive techniques, while emerging markets in the Middle East and Africa show increasing demand for cost-effective solutions. The Asia-Pacific region leads in volume growth, propelled by expanding healthcare access, rising breast cancer incidence awareness programs and government incentives to modernize hospital equipment. These regional nuances inform go-to-market strategies and localization efforts for manufacturers and service providers alike.

Key Company Insights and Competitive Dynamics

The competitive landscape features a mix of global leaders, specialist innovators and emerging challengers. Established medical device companies such as Argon Medical Devices, Inc. and Becton, Dickinson and Company maintain broad portfolios spanning marker-based tools and cryoablation systems. Other major players, including C.P. Medical and Cook Group, emphasize reliability and cost-efficiency in wire-guided and seed localization products. Hologic, Inc. and SOMATEX Medical Technologies GmbH, backed by strong imaging software capabilities, drive advances in integration and algorithmic support. Niche innovators like Cianna Medical, Endomagnetics Limited and Intramedical Imaging focus on non-radioactive seed localization and magnetically guided approaches, often partnering with surgical device manufacturers to co-develop seamless workflows.

Software pioneers such as ISOAID, LLC and Laurane Medical LLC leverage AI-enhanced imaging platforms to refine lesion detection and surgical planning, while Merit Medical Systems, Inc., Molli Surgical Inc. and Ranfac Corp. differentiate through modular device architectures. Collaborative ventures have also emerged: partnerships between Intramedical Imaging, LLC and radiology software firms expand intraoperative visualization, and strategic alliances involving Sterylab S.r.l. and Sirius Medical System B.V. target the pediatric and benign lesion segments. Collectively, these dynamics underscore a market in which scale, innovation and interoperability converge to define competitive advantage.

Actionable Recommendations for Industry Leaders

To secure leadership in the evolving breast lesion localization arena, decision-makers should pursue a multifaceted strategy. First, prioritize investment in AI-powered imaging software and augmented reality guidance, which have demonstrated tangible improvements in surgical precision and efficiency. Second, expand minimally invasive procedure offerings-particularly cryoablation and non-radioactive seed localization-to meet rising patient demand for faster recovery and reduced procedural discomfort. Third, develop flexible supply chain models by nurturing domestic manufacturing partnerships and dual-sourcing critical components to mitigate trade policy risks. Fourth, strengthen collaborations with radiology and oncology specialists to co-create tailored workflows and accelerate clinical adoption. Fifth, engage proactively with policymakers and payers to advocate for favorable reimbursement pathways, highlighting cost-utility data and patient quality-of-life outcomes. Finally, consider strategic alliances or acquisitions that bolster software capabilities or broaden geographic reach, thereby enhancing end-to-end solution portfolios.

Conclusion: Navigating the Next Phase of Localization Innovation

The breast lesion localization market stands at a pivotal juncture defined by converging technology innovations, evolving trade policies and shifting clinical demands. Stakeholders who harness advanced imaging, embrace emerging marker-based techniques and cultivate resilient supply chains will outperform competitors. A deep understanding of segmentation dynamics-from technology preferences to end-user needs and regional nuances-provides the foundation for targeted growth strategies. As the industry advances toward greater precision, fewer invasive procedures and seamless interdisciplinary workflows, the organizations that invest strategically in cutting-edge solutions and foster cross-sector partnerships will lead the next wave of clinical excellence and market expansion.

Market Segmentation & Coverage

This research report categorizes the Breast Lesion Localization Methods Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Advanced Techniques
    • Cryoablation
    • Robotic-Assisted Localization
  • Emerging Technologies
    • AI-powered Solutions
    • Augmented Reality Guided Approaches
  • Imaging-Based
    • Magnetic Resonance Imaging (MRI)
    • Mammography
    • Optical Imaging
    • Ultrasound
  • Marker-Based
    • Non-Radioactive Seed Localization
    • Radioactive Seed Localization
    • Wire-Guided Localization
  • Ambulatory Surgery Centers
  • Diagnostic Centers
  • Hospitals & Clinics
    • Private Clinics
    • Public Hospitals
  • Research Institutes
  • Devices
    • Handheld Devices
    • Stationary Systems
  • Software Solutions
    • Imaging Software
  • Adult
    • Middle-Aged Adult
    • Senior Adult
    • Young Adult
  • Pediatric
  • Primary Care Providers
  • Specialists
    • Oncologists
    • Radiologists
  • Benign
  • Malignant
    • Ductal Carcinoma
    • Lobular Carcinoma
  • Invasive Procedures
  • Minimally Invasive Procedures
  • Non-Invasive Procedures

This research report categorizes the Breast Lesion Localization Methods Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Breast Lesion Localization Methods Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Argon Medical Devices, Inc.
  • Becton, Dickinson and Company
  • BIOPSYBELL S.R.L.
  • C.P. Medical
  • Cianna Medical, Inc.
  • Cook Group
  • Endomagnetics Limited
  • Hologic, Inc.
  • ILUMARK GmbH
  • Intramedical Imaging
  • Intramedical Imaging, LLC
  • IsoAid, LLC
  • IZI Medical Products by Halma PLC
  • Laurane Medical LLC
  • Merit Medical Systems, Inc.
  • Mermaid Medical
  • Molli Surgical Inc.
  • Ranfac Corp.
  • Sirius Medical System B.V.
  • SOMATEX Medical Technologies GmbH by Hologic
  • Sterylab S.r.l.
  • Stryker Corporation
  • Wright Medical Group N.V.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Breast Lesion Localization Methods Market, by Technology Type
8.1. Introduction
8.2. Advanced Techniques
8.2.1. Cryoablation
8.2.2. Robotic-Assisted Localization
8.3. Emerging Technologies
8.3.1. AI-powered Solutions
8.3.2. Augmented Reality Guided Approaches
8.4. Imaging-Based
8.4.1. Magnetic Resonance Imaging (MRI)
8.4.2. Mammography
8.4.3. Optical Imaging
8.4.4. Ultrasound
8.5. Marker-Based
8.5.1. Non-Radioactive Seed Localization
8.5.2. Radioactive Seed Localization
8.5.3. Wire-Guided Localization
9. Breast Lesion Localization Methods Market, by End User
9.1. Introduction
9.2. Ambulatory Surgery Centers
9.3. Diagnostic Centers
9.4. Hospitals & Clinics
9.4.1. Private Clinics
9.4.2. Public Hospitals
9.5. Research Institutes
10. Breast Lesion Localization Methods Market, by Product Type
10.1. Introduction
10.2. Devices
10.2.1. Handheld Devices
10.2.2. Stationary Systems
10.3. Software Solutions
10.3.1. Imaging Software
11. Breast Lesion Localization Methods Market, by Age Group
11.1. Introduction
11.2. Adult
11.2.1. Middle-Aged Adult
11.2.2. Senior Adult
11.2.3. Young Adult
11.3. Pediatric
12. Breast Lesion Localization Methods Market, by Provider Type
12.1. Introduction
12.2. Primary Care Providers
12.3. Specialists
12.3.1. Oncologists
12.3.2. Radiologists
13. Breast Lesion Localization Methods Market, by Type Of Lesion
13.1. Introduction
13.2. Benign
13.3. Malignant
13.3.1. Ductal Carcinoma
13.3.2. Lobular Carcinoma
14. Breast Lesion Localization Methods Market, by Degree Of Invasiveness
14.1. Introduction
14.2. Invasive Procedures
14.3. Minimally Invasive Procedures
14.4. Non-Invasive Procedures
15. Americas Breast Lesion Localization Methods Market
15.1. Introduction
15.2. Argentina
15.3. Brazil
15.4. Canada
15.5. Mexico
15.6. United States
16. Asia-Pacific Breast Lesion Localization Methods Market
16.1. Introduction
16.2. Australia
16.3. China
16.4. India
16.5. Indonesia
16.6. Japan
16.7. Malaysia
16.8. Philippines
16.9. Singapore
16.10. South Korea
16.11. Taiwan
16.12. Thailand
16.13. Vietnam
17. Europe, Middle East & Africa Breast Lesion Localization Methods Market
17.1. Introduction
17.2. Denmark
17.3. Egypt
17.4. Finland
17.5. France
17.6. Germany
17.7. Israel
17.8. Italy
17.9. Netherlands
17.10. Nigeria
17.11. Norway
17.12. Poland
17.13. Qatar
17.14. Russia
17.15. Saudi Arabia
17.16. South Africa
17.17. Spain
17.18. Sweden
17.19. Switzerland
17.20. Turkey
17.21. United Arab Emirates
17.22. United Kingdom
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. Argon Medical Devices, Inc.
18.3.2. Becton, Dickinson and Company
18.3.3. BIOPSYBELL S.R.L.
18.3.4. C.P. Medical
18.3.5. Cianna Medical, Inc.
18.3.6. Cook Group
18.3.7. Endomagnetics Limited
18.3.8. Hologic, Inc.
18.3.9. ILUMARK GmbH
18.3.10. Intramedical Imaging
18.3.11. Intramedical Imaging, LLC
18.3.12. IsoAid, LLC
18.3.13. IZI Medical Products by Halma PLC
18.3.14. Laurane Medical LLC
18.3.15. Merit Medical Systems, Inc.
18.3.16. Mermaid Medical
18.3.17. Molli Surgical Inc.
18.3.18. Ranfac Corp.
18.3.19. Sirius Medical System B.V.
18.3.20. SOMATEX Medical Technologies GmbH by Hologic
18.3.21. Sterylab S.r.l.
18.3.22. Stryker Corporation
18.3.23. Wright Medical Group N.V.
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. BREAST LESION LOCALIZATION METHODS MARKET MULTI-CURRENCY
FIGURE 2. BREAST LESION LOCALIZATION METHODS MARKET MULTI-LANGUAGE
FIGURE 3. BREAST LESION LOCALIZATION METHODS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TECHNOLOGY TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TECHNOLOGY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY PROVIDER TYPE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY PROVIDER TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE OF LESION, 2024 VS 2030 (%)
FIGURE 18. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE OF LESION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY DEGREE OF INVASIVENESS, 2024 VS 2030 (%)
FIGURE 20. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY DEGREE OF INVASIVENESS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. AMERICAS BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. AMERICAS BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. UNITED STATES BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 24. UNITED STATES BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. EUROPE, MIDDLE EAST & AFRICA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. EUROPE, MIDDLE EAST & AFRICA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. BREAST LESION LOCALIZATION METHODS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 30. BREAST LESION LOCALIZATION METHODS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BREAST LESION LOCALIZATION METHODS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY ADVANCED TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY CRYOABLATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY ROBOTIC-ASSISTED LOCALIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY ADVANCED TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY EMERGING TECHNOLOGIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY AI-POWERED SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY AUGMENTED REALITY GUIDED APPROACHES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY EMERGING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY IMAGING-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI), BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MAMMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY OPTICAL IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY IMAGING-BASED, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MARKER-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY NON-RADIOACTIVE SEED LOCALIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY RADIOACTIVE SEED LOCALIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY WIRE-GUIDED LOCALIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MARKER-BASED, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY PRIVATE CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY HANDHELD DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY STATIONARY SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY SOFTWARE SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY IMAGING SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY SOFTWARE SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MIDDLE-AGED ADULT, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY SENIOR ADULT, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY YOUNG ADULT, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY ADULT, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY PROVIDER TYPE, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY PRIMARY CARE PROVIDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY SPECIALISTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY ONCOLOGISTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY RADIOLOGISTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY SPECIALISTS, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE OF LESION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY BENIGN, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MALIGNANT, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY DUCTAL CARCINOMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY LOBULAR CARCINOMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MALIGNANT, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY DEGREE OF INVASIVENESS, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY INVASIVE PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MINIMALLY INVASIVE PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY NON-INVASIVE PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY ADVANCED TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY EMERGING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY IMAGING-BASED, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MARKER-BASED, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY SOFTWARE SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY ADULT, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY PROVIDER TYPE, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY SPECIALISTS, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE OF LESION, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MALIGNANT, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY DEGREE OF INVASIVENESS, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 83. ARGENTINA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 84. ARGENTINA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY ADVANCED TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 85. ARGENTINA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY EMERGING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 86. ARGENTINA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY IMAGING-BASED, 2018-2030 (USD MILLION)
TABLE 87. ARGENTINA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MARKER-BASED, 2018-2030 (USD MILLION)
TABLE 88. ARGENTINA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 89. ARGENTINA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 90. ARGENTINA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 91. ARGENTINA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY SOFTWARE SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 94. ARGENTINA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY ADULT, 2018-2030 (USD MILLION)
TABLE 95. ARGENTINA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY PROVIDER TYPE, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY SPECIALISTS, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE OF LESION, 2018-2030 (USD MILLION)
TABLE 98. ARGENTINA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MALIGNANT, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY DEGREE OF INVASIVENESS, 2018-2030 (USD MILLION)
TABLE 100. BRAZIL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 101. BRAZIL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY ADVANCED TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 102. BRAZIL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY EMERGING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 103. BRAZIL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY IMAGING-BASED, 2018-2030 (USD MILLION)
TABLE 104. BRAZIL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MARKER-BASED, 2018-2030 (USD MILLION)
TABLE 105. BRAZIL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 106. BRAZIL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 107. BRAZIL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 108. BRAZIL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 109. BRAZIL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY SOFTWARE SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 110. BRAZIL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 111. BRAZIL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY ADULT, 2018-2030 (USD MILLION)
TABLE 112. BRAZIL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY PROVIDER TYPE, 2018-2030 (USD MILLION)
TABLE 113. BRAZIL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY SPECIALISTS, 2018-2030 (USD MILLION)
TABLE 114. BRAZIL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE OF LESION, 2018-2030 (USD MILLION)
TABLE 115. BRAZIL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MALIGNANT, 2018-2030 (USD MILLION)
TABLE 116. BRAZIL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY DEGREE OF INVASIVENESS, 2018-2030 (USD MILLION)
TABLE 117. CANADA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 118. CANADA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY ADVANCED TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 119. CANADA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY EMERGING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 120. CANADA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY IMAGING-BASED, 2018-2030 (USD MILLION)
TABLE 121. CANADA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MARKER-BASED, 2018-2030 (USD MILLION)
TABLE 122. CANADA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 123. CANADA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 124. CANADA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 125. CANADA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 126. CANADA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY SOFTWARE SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 127. CANADA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 128. CANADA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY ADULT, 2018-2030 (USD MILLION)
TABLE 129. CANADA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY PROVIDER TYPE, 2018-2030 (USD MILLION)
TABLE 130. CANADA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY SPECIALISTS, 2018-2030 (USD MILLION)
TABLE 131. CANADA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE OF LESION, 2018-2030 (USD MILLION)
TABLE 132. CANADA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MALIGNANT, 2018-2030 (USD MILLION)
TABLE 133. CANADA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY DEGREE OF INVASIVENESS, 2018-2030 (USD MILLION)
TABLE 134. MEXICO BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 135. MEXICO BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY ADVANCED TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 136. MEXICO BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY EMERGING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 137. MEXICO BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY IMAGING-BASED, 2018-2030 (USD MILLION)
TABLE 138. MEXICO BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MARKER-BASED, 2018-2030 (USD MILLION)
TABLE 139. MEXICO BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 140. MEXICO BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 141. MEXICO BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 142. MEXICO BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 143. MEXICO BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY SOFTWARE SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 144. MEXICO BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 145. MEXICO BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY ADULT, 2018-2030 (USD MILLION)
TABLE 146. MEXICO BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY PROVIDER TYPE, 2018-2030 (USD MILLION)
TABLE 147. MEXICO BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY SPECIALISTS, 2018-2030 (USD MILLION)
TABLE 148. MEXICO BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE OF LESION, 2018-2030 (USD MILLION)
TABLE 149. MEXICO BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MALIGNANT, 2018-2030 (USD MILLION)
TABLE 150. MEXICO BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY DEGREE OF INVASIVENESS, 2018-2030 (USD MILLION)
TABLE 151. UNITED STATES BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 152. UNITED STATES BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY ADVANCED TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 153. UNITED STATES BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY EMERGING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 154. UNITED STATES BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY IMAGING-BASED, 2018-2030 (USD MILLION)
TABLE 155. UNITED STATES BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MARKER-BASED, 2018-2030 (USD MILLION)
TABLE 156. UNITED STATES BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 157. UNITED STATES BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 158. UNITED STATES BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 159. UNITED STATES BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 160. UNITED STATES BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY SOFTWARE SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 161. UNITED STATES BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 162. UNITED STATES BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY ADULT, 2018-2030 (USD MILLION)
TABLE 163. UNITED STATES BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY PROVIDER TYPE, 2018-2030 (USD MILLION)
TABLE 164. UNITED STATES BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY SPECIALISTS, 2018-2030 (USD MILLION)
TABLE 165. UNITED STATES BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE OF LESION, 2018-2030 (USD MILLION)
TABLE 166. UNITED STATES BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MALIGNANT, 2018-2030 (USD MILLION)
TABLE 167. UNITED STATES BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY DEGREE OF INVASIVENESS, 2018-2030 (USD MILLION)
TABLE 168. UNITED STATES BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 169. ASIA-PACIFIC BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 170. ASIA-PACIFIC BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY ADVANCED TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 171. ASIA-PACIFIC BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY EMERGING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 172. ASIA-PACIFIC BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY IMAGING-BASED, 2018-2030 (USD MILLION)
TABLE 173. ASIA-PACIFIC BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MARKER-BASED, 2018-2030 (USD MILLION)
TABLE 174. ASIA-PACIFIC BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 175. ASIA-PACIFIC BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 176. ASIA-PACIFIC BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 177. ASIA-PACIFIC BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 178. ASIA-PACIFIC BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY SOFTWARE SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 179. ASIA-PACIFIC BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 180. ASIA-PACIFIC BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY ADULT, 2018-2030 (USD MILLION)
TABLE 181. ASIA-PACIFIC BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY PROVIDER TYPE, 2018-2030 (USD MILLION)
TABLE 182. ASIA-PACIFIC BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY SPECIALISTS, 2018-2030 (USD MILLION)
TABLE 183. ASIA-PACIFIC BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE OF LESION, 2018-2030 (USD MILLION)
TABLE 184. ASIA-PACIFIC BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MALIGNANT, 2018-2030 (USD MILLION)
TABLE 185. ASIA-PACIFIC BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY DEGREE OF INVASIVENESS, 2018-2030 (USD MILLION)
TABLE 186. ASIA-PACIFIC BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 187. AUSTRALIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 188. AUSTRALIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY ADVANCED TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 189. AUSTRALIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY EMERGING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 190. AUSTRALIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY IMAGING-BASED, 2018-2030 (USD MILLION)
TABLE 191. AUSTRALIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MARKER-BASED, 2018-2030 (USD MILLION)
TABLE 192. AUSTRALIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 193. AUSTRALIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 194. AUSTRALIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 195. AUSTRALIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 196. AUSTRALIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY SOFTWARE SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 197. AUSTRALIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 198. AUSTRALIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY ADULT, 2018-2030 (USD MILLION)
TABLE 199. AUSTRALIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY PROVIDER TYPE, 2018-2030 (USD MILLION)
TABLE 200. AUSTRALIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY SPECIALISTS, 2018-2030 (USD MILLION)
TABLE 201. AUSTRALIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE OF LESION, 2018-2030 (USD MILLION)
TABLE 202. AUSTRALIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MALIGNANT, 2018-2030 (USD MILLION)
TABLE 203. AUSTRALIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY DEGREE OF INVASIVENESS, 2018-2030 (USD MILLION)
TABLE 204. CHINA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 205. CHINA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY ADVANCED TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 206. CHINA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY EMERGING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 207. CHINA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY IMAGING-BASED, 2018-2030 (USD MILLION)
TABLE 208. CHINA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MARKER-BASED, 2018-2030 (USD MILLION)
TABLE 209. CHINA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 210. CHINA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 211. CHINA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 212. CHINA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 213. CHINA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY SOFTWARE SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 214. CHINA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 215. CHINA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY ADULT, 2018-2030 (USD MILLION)
TABLE 216. CHINA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY PROVIDER TYPE, 2018-2030 (USD MILLION)
TABLE 217. CHINA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY SPECIALISTS, 2018-2030 (USD MILLION)
TABLE 218. CHINA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE OF LESION, 2018-2030 (USD MILLION)
TABLE 219. CHINA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MALIGNANT, 2018-2030 (USD MILLION)
TABLE 220. CHINA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY DEGREE OF INVASIVENESS, 2018-2030 (USD MILLION)
TABLE 221. INDIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 222. INDIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY ADVANCED TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 223. INDIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY EMERGING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 224. INDIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY IMAGING-BASED, 2018-2030 (USD MILLION)
TABLE 225. INDIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MARKER-BASED, 2018-2030 (USD MILLION)
TABLE 226. INDIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 227. INDIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 228. INDIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 229. INDIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 230. INDIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY SOFTWARE SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 231. INDIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 232. INDIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY ADULT, 2018-2030 (USD MILLION)
TABLE 233. INDIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY PROVIDER TYPE, 2018-2030 (USD MILLION)
TABLE 234. INDIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY SPECIALISTS, 2018-2030 (USD MILLION)
TABLE 235. INDIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE OF LESION, 2018-2030 (USD MILLION)
TABLE 236. INDIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MALIGNANT, 2018-2030 (USD MILLION)
TABLE 237. INDIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY DEGREE OF INVASIVENESS, 2018-2030 (USD MILLION)
TABLE 238. INDONESIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 239. INDONESIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY ADVANCED TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 240. INDONESIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY EMERGING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 241. INDONESIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY IMAGING-BASED, 2018-2030 (USD MILLION)
TABLE 242. INDONESIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MARKER-BASED, 2018-2030 (USD MILLION)
TABLE 243. INDONESIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 244. INDONESIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 245. INDONESIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 246. INDONESIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 247. INDONESIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY SOFTWARE SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 248. INDONESIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 249. INDONESIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY ADULT, 2018-2030 (USD MILLION)
TABLE 250. INDONESIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY PROVIDER TYPE, 2018-2030 (USD MILLION)
TABLE 251. INDONESIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY SPECIALISTS, 2018-2030 (USD MILLION)
TABLE 252. INDONESIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE OF LESION, 2018-2030 (USD MILLION)
TABLE 253. INDONESIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MALIGNANT, 2018-2030 (USD MILLION)
TABLE 254. INDONESIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY DEGREE OF INVASIVENESS, 2018-2030 (USD MILLION)
TABLE 255. JAPAN BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 256. JAPAN BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY ADVANCED TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 257. JAPAN BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY EMERGING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 258. JAPAN BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY IMAGING-BASED, 2018-2030 (USD MILLION)
TABLE 259. JAPAN BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MARKER-BASED, 2018-2030 (USD MILLION)
TABLE 260. JAPAN BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 261. JAPAN BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 262. JAPAN BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 263. JAPAN BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 264. JAPAN BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY SOFTWARE SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 265. JAPAN BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 266. JAPAN BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY ADULT, 2018-2030 (USD MILLION)
TABLE 267. JAPAN BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY PROVIDER TYPE, 2018-2030 (USD MILLION)
TABLE 268. JAPAN BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY SPECIALISTS, 2018-2030 (USD MILLION)
TABLE 269. JAPAN BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE OF LESION, 2018-2030 (USD MILLION)
TABLE 270. JAPAN BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MALIGNANT, 2018-2030 (USD MILLION)
TABLE 271. JAPAN BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY DEGREE OF INVASIVENESS, 2018-2030 (USD MILLION)
TABLE 272. MALAYSIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 273. MALAYSIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY ADVANCED TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 274. MALAYSIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY EMERGING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 275. MALAYSIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY IMAGING-BASED, 2018-2030 (USD MILLION)
TABLE 276. MALAYSIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MARKER-BASED, 2018-2030 (USD MILLION)
TABLE 277. MALAYSIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 278. MALAYSIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 279. MALAYSIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 280. MALAYSIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 281. MALAYSIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY SOFTWARE SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 282. MALAYSIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 283. MALAYSIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY ADULT, 2018-2030 (USD MILLION)
TABLE 284. MALAYSIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY PROVIDER TYPE, 2018-2030 (USD MILLION)
TABLE 285. MALAYSIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY SPECIALISTS, 2018-2030 (USD MILLION)
TABLE 286. MALAYSIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE OF LESION, 2018-2030 (USD MILLION)
TABLE 287. MALAYSIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MALIGNANT, 2018-2030 (USD MILLION)
TABLE 288. MALAYSIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY DEGREE OF INVASIVENESS, 2018-2030 (USD MILLION)
TABLE 289. PHILIPPINES BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 290. PHILIPPINES BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY ADVANCED TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 291. PHILIPPINES BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY EMERGING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 292. PHILIPPINES BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY IMAGING-BASED, 2018-2030 (USD MILLION)
TABLE 293. PHILIPPINES BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MARKER-BASED, 2018-2030 (USD MILLION)
TABLE 294. PHILIPPINES BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 295. PHILIPPINES BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY HO

Companies Mentioned

  • Argon Medical Devices, Inc.
  • Becton, Dickinson and Company
  • BIOPSYBELL S.R.L.
  • C.P. Medical
  • Cianna Medical, Inc.
  • Cook Group
  • Endomagnetics Limited
  • Hologic, Inc.
  • ILUMARK GmbH
  • Intramedical Imaging
  • Intramedical Imaging, LLC
  • IsoAid, LLC
  • IZI Medical Products by Halma PLC
  • Laurane Medical LLC
  • Merit Medical Systems, Inc.
  • Mermaid Medical
  • Molli Surgical Inc.
  • Ranfac Corp.
  • Sirius Medical System B.V.
  • SOMATEX Medical Technologies GmbH by Hologic
  • Sterylab S.r.l.
  • Stryker Corporation
  • Wright Medical Group N.V.

Methodology

Loading
LOADING...

Related Topics

Related Reports

Breast Lesion Localization Methods Market Size, Share & Trends Analysis Report by Type (Wire Guided Localization, Radioisotope Localization, Magnetic Tracer), and Region with Growth Forecasts, 2025-2030 - Product Image

Breast Lesion Localization Methods Market Size, Share & Trends Analysis Report by Type (Wire Guided Localization, Radioisotope Localization, Magnetic Tracer), and Region with Growth Forecasts, 2025-2030

  • Report
  • 100 Pages
  • Global
From
Breast Lesion Localization Methods Market Report by Type, Usage, End User, and Region 2025-2033 - Product Image

Breast Lesion Localization Methods Market Report by Type, Usage, End User, and Region 2025-2033

  • Report
  • 150 Pages
  • Global
From
Breast Lesion Localization - Global Strategic Business Report - Product Image

Breast Lesion Localization - Global Strategic Business Report

  • Report
  • 193 Pages
  • Global
From
Breast Lesion Localization Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032) - Product Image

Breast Lesion Localization Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032)

  • Report
  • 154 Pages
  • Global
From
Breast Lesion Localization Methods Market by Type, Techniques, by End User, and By Region - Product Image

Breast Lesion Localization Methods Market by Type, Techniques, by End User, and By Region

  • Report
  • 200 Pages
  • Global
From

About the Breast Lesion Localization Market

The Breast Lesion Localization market is a subset of the larger Surgical Procedures market. It involves the use of imaging technology to identify and localize breast lesions prior to surgery. This technology is used to help surgeons accurately locate and remove lesions, reducing the risk of incomplete removal or unnecessary tissue removal. It also helps to reduce the amount of time spent in the operating room, as well as the amount of radiation exposure to the patient. The Breast Lesion Localization market is composed of a variety of companies, including those that develop and manufacture imaging technology, as well as those that provide services related to the use of the technology. Examples of companies in this market include Hologic, Inc., Cianna Medical, Inc., and Seno Medical Instruments, Inc. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.